Is there any association of serum high-sensitivity C-reactive protein with various risk factors for metabolic syndrome in a healthy adult population of Karachi, Pakistan?

Metabolic Syndrome and Related Disorders

Volumn 9, Issue 3, 2011, Pages 177-182

  Riaz, Mussarat ^a   Fawwad, Asher ^a   Hydrie, M Zafar Iqbal ^a   Basit, Abdul ^a   Shera, A Samad ^b  

^a BAQAI MEDICAL UNIVERSITY   (Pakistan)

^b Diabetic Association of Pakistan   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HIP; HOMEOSTASIS MODEL ASSESSMENT OF INSULIN RESISTANCE; HUMAN; IMAGING SYSTEM; INSULIN RESISTANCE; INTERNATIONAL DIABETES FEDERATION CRITERIA; MALE; METABOLIC SYNDROME X; NORMAL HUMAN; PAKISTAN; PRIORITY JOURNAL; RISK FACTOR; URBAN POPULATION; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; BLOOD PRESSURE; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PAKISTAN; POPULATION; RISK FACTORS;

EID: 79957637834     PISSN: 15404196     EISSN: 15578518     Source Type: Journal    
DOI: 10.1089/met.2010.0113     Document Type: Article

References (27)

1. Alexander RW. Inflammation and coronary artery disease. New Engl J Med 1994;331:468-469. (Pubitemid 24247405)
2. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med 2002;347:1557-1565. (Pubitemid 35315836)
3. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation 2003;107:391-397.
4. Ridker PM. High-sensitivity C-reactive protein. Potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 2001;103:1813-1818. (Pubitemid 32291421)
5. Temelkova-Kurktschiev T, Siegert G, Bergmann S, Henkel E, Koehler C, Jaross W, Hanefeld M. Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes. Metabolism 2002;51:743-749. (Pubitemid 34624841)
6. McKeigue PM, Shah B, Marmot MG. Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 1991;337:382-386.
7. McKeigue PM, Ferrie JE, Pierpoint T, Association of earlyonset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia. Circulation 1993;87:152-161. (Pubitemid 23019345)
8. Forouhi NG, Sattar N, McKeigue PM. Relation of C-reactive protein to body fat distribution and features of the metabolic syndrome in Europeans and South Asians. Int J Obes Relat Metab Disord 2001;25:1327.
9. Sethi A, Misra A, Pandey RM. Soluble inter-cellular adhesion molecule-1 in urban Asian North Indians: Relationships with anthropometric and metabolic covariates. Dis Markers 2002;18:111.
10. Vikram NK, Misra A, Dwivedi M, Sharma R, Pandey RM, Luthra K, Chatterjee A, Guleria R. Correlations of C-reactive protein levels with anthropometric profile, percentage of body fat and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis 2003;168:305-313. (Pubitemid 36703330)
11. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. J Am Med Assoc 2000;282:2131-2135.
12. Hydrie MZI, Shera AS, Fawwad A, Basit A, Hussain A. Prevalence of metabolic syndrome in urban Pakistan (Karachi): Comparison of newly proposed IDF and modified ATP III criteria. J Metabol Syndr Rel Disord 2009;7:119-124.
13. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome. Avalible at http://www.idf.org/webdata/docs/IDF- Metasyndrome-definition.pdf/.
14. Standards of Medical Care in Diabetes-2006. Diabetes Care 2006;29:S4-S42. Avalible at http://care.diabetesjournals.org/content/29/suppl-1/s4.full.pdf= html/.
15. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419. (Pubitemid 15018832)
16. Chambers JC, Eda S, Bassett P, Karim Y, Thompson SG, Gallimore JR, Pepys MB, Kooner JS. C-reactive protein, insulin resistance, central obesity, and coronary heart disease risk in Indian Asians from the United Kingdom compared with European whites. Circulation 2001;104:145-150. (Pubitemid 32655829)
17. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999;19:972-978. (Pubitemid 29177345)
18. Vikram NK, Misra A, Pandey RM, Dwivedi M, Luthra K, Dhingra V, Talwar KK. Association between subclinical inflammation & fasting insulin in urban young adult north Indian males. Indian J Med Res 2006;124:677-682. (Pubitemid 46592108)
19. Wang Z, Hoy WE. Population distribution of high sensitivity C-reactive protein values in aboriginal Australians: A comparison with other population. Clin Biochem 2006;39:277-281.
20. Albert MA, Ridker PM. C-reactive protein as a risk predictor: Do race/ethnicity and gender make a difference? Circulation 2006;114:67-74.
21. Anand SS, Yusuf S, Vuksan V, Devanesen S, Teo KK, Montague PA, Kelemen L, Yi C, Lonn E, Gerstein H, Hegele RA, McQueen M. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: T Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000;356:279-284. (Pubitemid 30459585)
22. Lakoski SG, Cushman M, Criqui M, Rundek T, Blumenthal RS, D"Agostino RB, Herrington DM. Gender and CRP: Data from multiethnic study of atherosclerosis (MESA) cohort. Am Heart J 2006;152:593-598. (Pubitemid 44233418)
23. Khan DA, Ansari WM, Saleem S, Khan FA. Reference value for high sensitivity C-reactive protein in the northern Pakistani population. Pak Armed Forces Med J 2009;59:420-424.
24. Pepys MB, Hirschfield GM. C-reaction protein: A critical update. J Clin Invest 2003;111:1805.
25. Zwaka TP, Hombach V, Torzewski J. C-reactive protein mediated low density lipoprotein update by macrophages: Implications for atherosclerosis. Circulation 2001;103:1194.
26. Pearson TA, Menash GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC, Taubert K, Tracy RP, Vinicor F. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professional from the centers for disease control and prevention and American Heart Association. Circulation 2003;107:499.
27. Yeh ET, Willerson JT. Coming of age of C-reactive protein: Using inflammation markers in cardiology. Circulation 2003;107:370.